Pacira BioSciences, Inc.PCRXNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank79
3Y CAGR-8.0%
5Y CAGR+2.1%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-8.0%/yr
vs +21.1%/yr prior
5Y CAGR
+2.1%/yr
Recent deceleration
Acceleration
-29.1pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 16.40% | +294.8% |
| 2024 | 4.15% | -81.9% |
| 2023 | 22.90% | +8.8% |
| 2022 | 21.05% | +0.0% |
| 2021 | 21.04% | +42.3% |
| 2020 | 14.78% | +102.4% |
| 2019 | 7.30% | -25.5% |
| 2018 | 9.80% | +365.2% |
| 2017 | -3.70% | +42.8% |
| 2016 | -6.46% | - |